Article Details

FDA approval for Keytruda/Herceptin combination in first-line advanced gastric cancer

Retrieved on: 2021-05-07 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

FDA approval for Keytruda/Herceptin combination in first-line advanced gastric cancer. View article details on hiswai:

Excerpt

The US Food and Drug Administration (FDA) has approved Merck & Co's Keytruda plus Roche's Herceptin and chemotherapy in the first-line setting ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up